Business Context and Reporting Period
Cardinal Health, Inc. filed a Form 8-K on October 7, 2025, reporting the entry into a new material definitive agreement. The filing details the execution of a 364-Day Credit Agreement with Bank of America, N.A., as Administrative Agent, following the expiration of the prior agreement from October 2024.
Key Financial Metrics and Liquidity
- Revolving Credit Facility: $1.0 billion available through October 6, 2026.
- Loan Conversion Option: Outstanding principal may be converted to non-revolving term loans repayable one year after the termination date.
- Financial Covenant: Maximum Consolidated Net Leverage Ratio of 3.75 to 1.00 as of the last day of any fiscal quarter.
- Usage: General corporate purposes and backing for the commercial paper program.
The filing text does not provide specific values for revenue, profit, cash flow, margins, or total debt outstanding as of the reporting date.
Material Changes Versus Prior Period
The primary material change is the renewal of the short-term credit facility. The new agreement replaces the 364-Day Credit Agreement entered into in October 2024, maintaining access to $1.0 billion in revolving credit with a termination date extended to October 6, 2026.
Guidance, Outlook, and Risks
Management Commentary: The agreement contains customary representations, affirmative and negative covenants, and events of default, including non-payment of principal or interest and covenant breaches.
Risks and Contingencies: The Company is subject to the financial covenant requiring a Consolidated Net Leverage Ratio not exceeding 3.75 to 1.00. Failure to maintain this ratio could trigger a default under the agreement.
Related Party Transactions: Certain financial institutions involved in the Credit Agreement or commercial paper program may perform other services for the Company, for which customary fees are paid.
Key Facts for Investor Verification
- Verify the current Consolidated Net Leverage Ratio to ensure compliance with the 3.75 to 1.00 covenant.
- Confirm the utilization rate of the $1.0 billion revolving credit facility.
- Review the full terms of the Credit Agreement (Exhibit 10.1) for specific conditions regarding the conversion of loans to term debt.
- Monitor the status of the commercial paper program backed by this facility.